Offer - Urjas Oil for just ₹ 1
Prumotiza Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Prumotiza Tablet safe for pregnant women?
Prumotiza may have some side effects during pregnancy. Pregnant women should discontinue the use of Prumotiza, and talk to their doctor, if they notice any discomfort.
Is the use of Prumotiza Tablet safe during breastfeeding?
Prumotiza may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Prumotiza Tablet on the Kidneys?
Prumotiza rarely harms the kidneys.
What is the effect of Prumotiza Tablet on the Liver?
Prumotiza is rarely harmful for the liver.
What is the effect of Prumotiza Tablet on the Heart?
Prumotiza is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Prumotiza Tablet unless your doctor advises you to do so -
Is this Prumotiza Tablet habit forming or addictive?
No, you will not get addicted to Prumotiza Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Prumotiza Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Prumotiza Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Prumotiza Tablet is unable to treat or cure mental disorders.
Interaction between Food and Prumotiza Tablet
Due to a lack of research, nothing can be said about the consequences of taking Prumotiza Tablet together with food.
Interaction between Alcohol and Prumotiza Tablet
It is difficult to say anything about the effect of Prumotiza Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1319-1320
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 675
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Motegrity (prucalopride)
